Zilver PTX Post-Market Study in Japan

Cook Group

Status: Completed

Conditions: Peripheral Arterial Disease (PAD)

Treatments: Device: Zilver PTX Drug-Eluting Stent

Study type: Interventional

Funder types: Industry

Identifiers

NCT02254837

12-005-PTX

Details and patient eligibility

About

Japanese post market clinical study of the Zilver PTX device.

Enrollment: 909 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Symptomatic peripheral arterial disease (PAD) involving the above-the-knee femoropopliteal arteries

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

909 participants in 1 patient group

Zilver PTX

Experimental group

Treatment:

Device: Zilver PTX Drug-Eluting Stent